Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients | Zendy

Laure Écotière | Zendy; Antoine Thierry | Zendy; Céline Debiais-Delpech | Zendy; Sylvie Chevret | Zendy; Vincent Javaugue | Zendy; Éstelle Desport | Zendy; S. Belmouaz | Zendy; Nathalie Quellard | Zendy; Sihem Kaaki | Zendy; Jean Michel Goujon | Zendy; JeanPaul Fermand | Zendy; Guy Touchard | Zendy; Frank Bridoux | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients

Author(s) -

Laure Écotière,

Antoine Thierry,

Céline Debiais-Delpech,

Sylvie Chevret,

Vincent Javaugue,

Éstelle Desport,

S. Belmouaz,

Nathalie Quellard,

Sihem Kaaki,

Jean Michel Goujon,

JeanPaul Fermand,

Guy Touchard,

Frank Bridoux

Publication year - 2015

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfv283

Subject(s) - medicine , renal function , multiple myeloma , odds ratio , urology , nephropathy , gastroenterology , dialysis , kidney disease , renal biopsy , population , kidney , confidence interval , hemodialysis , creatinine , endocrinology , diabetes mellitus , environmental health

Light chain myeloma cast nephropathy (MCN) is the major cause of renal failure in multiple myeloma and strongly impacts patient survival. The role of kidney biopsy in the management of MCN is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research